|
|
||
|
|
New drug development is the core business of BioLite. We integrate resourses from industry and academia to accelerate new drug discovery and development. |
| New drug development is the core of BioLite. We integrate resourses from industry and academia to accelerate new drug discovery and development. The new drug development strategy developed by our management team is to lead drug candidates from pre-clinical development stage to clinical stage. We have the most updated technologies and in-depth knowledge of local and international regulatory requirements at each stage of new drug development. During development process or upon receiving preliminary positive result, we take proactive approach to search for licensing and co-development partners from Europe, United States and Japan. We co-develope with our overseas pharmaceutical partners to reduce the risk and to maximize profit of new drug development. Meanwhile, BioLite cultivates and focuses on the business in Greater China Market. | Pipeline of Drug Discovery & Development |
 |